Ola Landgren, MD, PhD

Articles by Ola Landgren, MD, PhD

Ola Landgren, MD, PhDMyeloma | June 17, 2024
Ola Landgren, MD, PhD, discusses three studies on quadruplet therapy presented at the 2024 ASCO Annual Meeting.
Ola Landgren, MD, PhDMyeloma | August 18, 2021
Differentiation between MGUS and SMM is currently based on indirect measures and surrogate markers of disease burden.